News24.com | WHO-led Covax vaccine scheme agrees new supply deal with India's Serum

GENEVA/LONDON, Feb 3 - India's Serum Institute will supply 1.1 billion doses of COVID-19 vaccines developed by AstraZeneca and Novavax to the COVAX vaccine scheme as part of a new long-term deal, head of the U.N. Children's Fund said on Wednesday.